Dimitris A. Tsitsikas

Dr. Dimitris A. Tsitsikas


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Blood Reviews
Verified
Journal Article
Closed access
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
GGGiorgio Gallinella
Giorgio Gallinella
SPSneha Patel
Sneha Patel
HSHenry Seligman
Henry Seligman
PGPaul Greaves
Paul Greaves
RARoger J. Amos
Roger J. Amos

5 May 2020 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
KMKayleigh A. McCloskey
Kayleigh A. McCloskey
JMJohn Meenan
John Meenan
RHRhys Hall
Rhys Hall
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
During the COVID‐19 pandemic, patients with sickle cell disease (SCD) have been included in the "high risk" group of the population. This is due to their impaired immunity resulting from functional hyposplenism, systemic vasculopathy that predisposes them to end organ dysfunction, and a high risk of thrombosis (Ware et al, 2017).

8 November 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
JBJessica Bristowe
Jessica Bristowe
JAJibril Abukar
Jibril Abukar
Fat embolism syndrome is a devastating complication of sickle cell disease resulting from extensive bone marrow necrosis and associated with high mortality rates, while survivors often suffer severe neurological sequelae. Despite that, the syndrome remains under-recognised and under-diagnosed. Paradoxically, it affects exclusively patients with mild forms of sickle cell disease, predominantly HbSC and HbSβ+. A significant number of cases occur in the context of human parvovirus B19 infection. We provide here a brief summary of the existing literature and describe our experience treating 8 patients in our institution. One patient had HbSS, 6 HbSC and 1 HbSβ+. All patients developed type I respiratory failure and neurological involvement either at presentation or within the first 72 h. The most striking laboratory abnormality was a 100-fold increase of the serum ferritin from baseline. Seven patients received emergency red cell exchange and 1 simple transfusion. Two patients (25%) died, 2 patients (25%) suffered severe neurological impairment and 1 (12%) mild neurological impairment on discharge, while 3 (38%) patients made a complete recovery. With long-term follow-up, 1 patient with severe neurological impairment and one patient with mild neurological impairment made dramatic improvements, making the long-term complete recovery or near complete recovery rate 63%. Immediate red cell exchange transfusion can be lifesaving and should be instituted as soon as the syndrome is suspected. However, as the outcomes remain unsatisfactory despite the increasing use of red cell exchange, we suggest additional therapeutic measures such as therapeutic plasma exchange and pre-emptive transfusion for high risk patients.

8 March 2011 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
MBMorag Brothwell
Morag Brothwell
JAJo-Anne Chin Aleong
Jo-Anne Chin Aleong
ALAndrew T Lister
Andrew T Lister
Aim Hospital autopsy rates have been falling steadily over recent decades. One factor that has been implicated in this decline is the perception that the general public views postmortem examinations unfavourably and that this often makes clinicians reluctant to discuss autopsy with families and seek their consent. The aim of this study was to test this assumption. Objectives/methods In the division of lymphoid malignancies at St Bartholomew's Hospital, we suggested autopsy and discussed it in depth with the families of all the patients who died in hospital in an 8-month period in order to assess whether the autopsy rate could be increased by improving the approach to the relatives. Results Consent for a postmortem examination was requested in 18 of 23 cases and granted in 16 cases, giving a consent rate of 89%, and an overall rate of autopsy of 69.5%. Conclusion The attitude of the general public is positive overall, and translates into high autopsy rates when the value of the examination is presented honestly and the details of the procedure are adequately explained.

1 May 2019 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
JMJori E. May
Jori E. May
RGRadhika Gangaraju
Radhika Gangaraju
JAJibril Abukar
Jibril Abukar
RARoger J. Amos
Roger J. Amos
MMMarisa B. Marques
Marisa B. Marques
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

15 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DTDimitris A. Tsitsikas
Dimitris A. Tsitsikas
SBSaket Badle
Saket Badle
RHRhys Hall
Rhys Hall
JMJohn Meenan
John Meenan
OBOloruntoyin Bello-Sanyaolu
Oloruntoyin Bello-Sanyaolu
RARoger J. Amos
Roger J. Amos
Red cell transfusion represents one of the cornerstones of the chronic management of sickle cell disease, as well as its acute complications. Automated red cell exchange can rapidly lower the number of circulating sickle erythrocytes, without causing iron overload. Here, we describe our experience, having offered this intervention since 2011. A transient reduction in the platelet count by 61% was observed after the procedure. This was not associated with any haemorrhagic complications. Despite exposure to large volumes of blood, the alloimmunisation rate was only 0.027/100 units of red cells. The absence of any iron loading was confirmed by serial Ferriscans, performed over a number of years. However, patients with advanced chronic kidney disease showed evidence of iron loading due to reduced innate haemopoiesis and were subsequently switched to simple transfusions. A total of 59% of patients were on regular automated red cell exchange with a history of recurrent painful crises. A total of 77% responded clinically, as evidenced by at least a 25% reduction in their emergency hospital attendance for pain management. The clinical response was gradual and increased the longer patients stayed on the program. The earliest sign of clinical response was a reduction in the length of stay when these patients were hospitalised, indicating that a reduction in the severity of crises precedes the reduction in their frequency. Automated red cell exchange also appeared to be beneficial for patients with recurrent leg ulcers and severe, drug resistant stuttering priapism, while patients with pulmonary hypertension showed a dramatic improvement in their symptoms as well as echocardiographic parameters.